Essex Investment Management CO LLC Viking Therapeutics, Inc. Transaction History

Essex Investment Management CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$6.38 - $8.73 $319,000 - $436,500	-50,000 Closed	0 $0
Q3 2019 Oct 22, 2019	SELL	$6.55 - $8.6 $413,809 - $543,322	-63,177 Reduced 55.82%	50,000 $344,000
Q2 2019 Aug 15, 2019	SELL	$7.67 - $10.63 $346,407 - $480,093	-45,164 Reduced 28.52%	113,177 $939,000
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $794,111 - $1.04 Million	-104,764 Reduced 39.82%	158,341 $1.57 Million
Q4 2018 Feb 06, 2019	BUY	$7.16 - $16.21 $1.88 Million - $4.26 Million	263,105 New	263,105 $2.01 Million

426

63.1M

7.39M

5.13M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.87B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.